Differential Diagnosis of Malignant Lymphadenopathy Using Flow Cytometry on Fine Needle Aspirate: Report on 269 Cases.
fine needle aspiration
flow cytometry
lymphoma
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
20 Jan 2020
20 Jan 2020
Historique:
received:
25
11
2019
revised:
03
01
2020
accepted:
13
01
2020
entrez:
24
1
2020
pubmed:
24
1
2020
medline:
24
1
2020
Statut:
epublish
Résumé
Fine needle aspiration (FNA) is frequently the first noninvasive test used for the diagnostic workup of lymphadenopathy. There have been many studies showing its usefulness, especially in conjunction with other techniques for the diagnosis of lymphoma, but it remains inferior to histological examination. The data regarding this subject have mostly been reported mostly from first-world countries, but are scarce for emerging economies. Thus, the current study assesses the agreement between fine needle aspiration flow cytometry (FNA FC) and histology in the aforementioned region. We conducted a retrospective study including the FNA FC adenopathy diagnoses made between January 2011 and December 2016 at the Tygerberg Hospital, Cape Town, South Africa. Additional variables included were the histological diagnosis, sex and age of the included patients. In the descriptive part of the current study, 269 FNA FC samples were included. The most frequent diagnoses made on these were represented by B-cell lymphoma, reactive adenopathy, no abnormality detected (NAD), and non-hematological malignancy. In the analytical part of the current study, there were 115 cases included that had both valid FNA FC and histological diagnoses. It could be observed that FNA FC can correctly diagnose B-cell lymphoma in most cases, but it is a poor diagnostic tool especially for Hodgkin lymphoma in this setting as only a four-color flow cytometer was available for diagnosis. Moreover, FNA FC diagnosis of reactive adenopathy and of no abnormalities detected was shown to frequently hide a malignant disease. In countries with scarce resources, FNA FC represents a useful diagnostic tool in the case of B-cell lymphoma, but may misdiagnose reactive adenopathy. Thus, FNA FC should be used in a case-specific manner, in addition to as a screening tool, with the knowledge that in cases with a high clinical suspicion of lymphoma, histological diagnosis is a necessity.
Identifiants
pubmed: 31968576
pii: jcm9010283
doi: 10.3390/jcm9010283
pmc: PMC7019747
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Acta Cytol. 2016;60(4):302-314
pubmed: 27554776
PLoS One. 2015 Jun 19;10(6):e0130148
pubmed: 26091519
Arch Endocrinol Metab. 2015 Apr;59(2):190-4
pubmed: 25993684
Cancer Cytopathol. 2018 Sep;126(9):797-808
pubmed: 30194715
Cytojournal. 2012;9:5
pubmed: 22438859
Front Oncol. 2019 Sep 10;9:892
pubmed: 31552193
Thyroid. 2010 Sep;20(9):1019-23
pubmed: 20718685
Clin Otolaryngol. 2017 Jun;42(3):668-672
pubmed: 27882691
Acta Cytol. 2016;60(4):315-325
pubmed: 27537785
Cancer J. 2009 Mar-Apr;15(2):129-37
pubmed: 19390308
Arch Pathol Lab Med. 2003 Sep;127(9):1148-60
pubmed: 12946230
Cytopathology. 2019 Jul;30(4):370-377
pubmed: 30985042
Exp Mol Pathol. 2019 Feb;106:44-51
pubmed: 30465756
Am J Surg. 1998 Nov;176(5):413-7
pubmed: 9874424
Cytometry B Clin Cytom. 2019 Mar;96(2):116-127
pubmed: 30350336
Hematol Oncol Stem Cell Ther. 2011;4(1):37-40
pubmed: 21460605
Am J Clin Pathol. 2010 Jan;133(1):83-91
pubmed: 20023262
Med Pharm Rep. 2019 Oct;92(4):421-426
pubmed: 31750446
Transfus Apher Sci. 2007 Aug;37(1):71-9
pubmed: 17920333
J BUON. 2013 Jul-Sep;18(3):739-45
pubmed: 24065493
Blood Res. 2017 Sep;52(3):159-166
pubmed: 29043230
Diagn Cytopathol. 2004 Apr;30(4):268-70
pubmed: 15048964
Hum Pathol. 2016 Jul;53:192-4
pubmed: 27016488
Nat Rev Endocrinol. 2017 Jul;13(7):415-424
pubmed: 28361927
Appl Immunohistochem Mol Morphol. 2010 Jul;18(4):311-22
pubmed: 19247181
Acta Cytol. 2016;60(4):326-335
pubmed: 27414717
Histopathology. 2011 May;58(6):906-18
pubmed: 21438908
Biol Blood Marrow Transplant. 2016 Mar;22(3):493-8
pubmed: 26497906
Cancers (Basel). 2019 Sep 16;11(9):
pubmed: 31527543
Crit Rev Clin Lab Sci. 2015;52(5):232-41
pubmed: 26218036
Cancer. 2014 Dec 15;120(24):4005-6
pubmed: 25123910
Coll Antropol. 2010 Mar;34(1):131-7
pubmed: 20432741
Semin Hematol. 2015 Apr;52(2):67-76
pubmed: 25805586
Diagn Cytopathol. 2019 Jun;47(6):579-583
pubmed: 30794347
Cancer. 2004 Feb 25;102(1):55-65
pubmed: 14968418
Crit Rev Clin Lab Sci. 2018 Mar;55(2):102-114
pubmed: 29316828
Diagn Cytopathol. 2009 Sep;37(9):686-95
pubmed: 19373919
J Am Soc Cytopathol. 2017 Mar - Apr;6(2):80-88
pubmed: 31042638
Histol Histopathol. 2019 Jun;34(6):663-670
pubmed: 30467824
J Nippon Med Sch. 2019 Oct 15;:
pubmed: 31611506
Acta Cytol. 2016;60(4):344-353
pubmed: 27592067
Acta Cytol. 2007 May-Jun;51(3):390-8
pubmed: 17536541
J Am Soc Cytopathol. 2017 May - Jun;6(3):114-119
pubmed: 31043261